论文部分内容阅读
通过免疫组化染色检测了小儿恶性淋巴瘤中P53抑癌基因和 bcl-2癌基因表达水平,探讨两种基因的改变与小儿恶性淋巴瘤发生发展的关系,为临床诊断和判断预后提供参考。报告如下。材料和方法:选择小儿恶性淋巴瘤手术标本32例。其中非霍奇金恶性淋巴瘤20例(T 细胞型9
The expression of P53 suppressor gene and bcl-2 oncogene in pediatric malignant lymphoma was detected by immunohistochemical staining. The relationship between the changes of the two genes and the occurrence and development of pediatric malignant lymphoma was explored, which could provide reference for clinical diagnosis and prognosis. The report is as follows. Materials and Methods: 32 cases of pediatric malignant lymphoma were selected. Including non-Hodgkin’s lymphoma in 20 cases (T cell type 9